121 related articles for article (PubMed ID: 2582069)
1. [The significance of serum leucine aminopeptidase (P-LAP) determination in the gynecological malignancies].
Kobayashi H; Sakura H; Kurauchi O; Mizutani S
Nihon Sanka Fujinka Gakkai Zasshi; 1985 May; 37(5):696-702. PubMed ID: 2582069
[TBL] [Abstract][Full Text] [Related]
2. Significance of serum leucine aminopeptidase in tumours of female genital tract.
Gupta SK; Aziz M; Khan AA; Mohsin S
J Indian Med Assoc; 1989 Mar; 87(3):68-70. PubMed ID: 2778330
[TBL] [Abstract][Full Text] [Related]
3. Serum cystine aminopeptidase and leucine aminopeptidase activity in women with benign and malignant uterine and ovarian tumors.
Blum M; Sirota P
Isr J Med Sci; 1977 Sep; 13(9):875-80. PubMed ID: 924762
[TBL] [Abstract][Full Text] [Related]
4. Placental leucine aminopeptidase (P-LAP) and glucose transporter 4 (GLUT4) expression in benign, borderline, and malignant ovarian epithelia.
Shibata K; Kajiyama H; Mizokami Y; Ino K; Nomura S; Mizutani S; Terauchi M; Kikkawa F
Gynecol Oncol; 2005 Jul; 98(1):11-8. PubMed ID: 15907336
[TBL] [Abstract][Full Text] [Related]
5. Telomerase activity as a biological marker in some gynecological tumors: comparison with tissue and serum CA 125.
Novakovic S; Fras PA; Jezersek-Novakovic B
In Vivo; 2001; 15(4):327-32. PubMed ID: 11695225
[TBL] [Abstract][Full Text] [Related]
6. [Clinical significance of new tumor marker CA 125 in gynecological cancer--particularly usefulness in diagnosis of ovarian cancer].
Kimura E; Murae M; Koga R; Odawara Y; Nakabayashi Y; Yokoyama K; Nakata H; Totake T; Ochiai K; Yasuda M
Nihon Sanka Fujinka Gakkai Zasshi; 1984 Nov; 36(11):2121-8. PubMed ID: 6595320
[TBL] [Abstract][Full Text] [Related]
7. [Diagnostic usefulness of stepwise discriminant analysis employing the values of CA125, TPA, IAP, CEA and ferritin in sera measured simultaneously for gynecological malignant neoplasms].
Yabushita H; Masuda T; Hattori A; Noguchi M; Ito Y; Nakanishi M; Ishihara M
Nihon Sanka Fujinka Gakkai Zasshi; 1985 Sep; 37(9):1883-92. PubMed ID: 2997349
[TBL] [Abstract][Full Text] [Related]
8. [Clinical significance of sialic acid determinations in patients with gynecologic cancer].
Shimizu Y; Akagaki E; Hirota K; Kono M; Irie T; Miura S; Kurachi K; Okudaira Y
Nihon Sanka Fujinka Gakkai Zasshi; 1987 Jan; 39(1):49-55. PubMed ID: 3819514
[TBL] [Abstract][Full Text] [Related]
9. [Evaluation of serum ferritin in female genital neoplasms].
Dong MY
Zhonghua Fu Chan Ke Za Zhi; 1991 Jan; 26(1):21-3, 61. PubMed ID: 1848498
[TBL] [Abstract][Full Text] [Related]
10. [The clinical significance of tissue polypeptide antigen (TPA) in the patients with gynecologic tumor].
Inoue M; Inoue Y; Hiramatsu K; Tanaka Y; Yamasaki M; Ueda G; Minagawa J; Ozaki M; Yanagida T; Nishino H
Nihon Sanka Fujinka Gakkai Zasshi; 1984 May; 36(5):779-84. PubMed ID: 6736725
[TBL] [Abstract][Full Text] [Related]
11. Placenta-like alkaline phosphatase in gynecological cancers.
Kellen JA; Bush RS; Malkin A
Cancer Res; 1976 Jan; 36(1):269-71. PubMed ID: 1248005
[TBL] [Abstract][Full Text] [Related]
12. [Estimation of placental leucine aminopeptidase (P-LAP) in pregnancy sera].
Akiyama H; Mizutani S; Narita O; Tomoda Y; Saiki N
Nihon Sanka Fujinka Gakkai Zasshi; 1984 Dec; 36(12):2605-12. PubMed ID: 6520481
[TBL] [Abstract][Full Text] [Related]
13. Plasma angiotensin I concentration and serum placental leucine aminopeptidase (P-LAP) activities in puerperal hypertension.
Mizutani S; Tomoda Y
Res Commun Chem Pathol Pharmacol; 1993 Sep; 81(3):271-91. PubMed ID: 8235062
[TBL] [Abstract][Full Text] [Related]
14. Soluble urokinase plasminogen activator receptor in preoperatively obtained plasma from patients with gynecological cancer or benign gynecological diseases.
Riisbro R; Stephens RW; Brünner N; Christensen IJ; Nielsen HJ; Heilmann L; von Tempelhoff GF
Gynecol Oncol; 2001 Sep; 82(3):523-31. PubMed ID: 11520150
[TBL] [Abstract][Full Text] [Related]
15. Changes in plasma renin activity (PRA), angiotensin I and placental leucine aminopeptidase (P-LAP) activity during normal pregnancy.
Mizutani S; Sakura H; Akiyama H; Kobayashi H
Nihon Sanka Fujinka Gakkai Zasshi; 1983 Apr; 35(4):545-9. PubMed ID: 6343531
[TBL] [Abstract][Full Text] [Related]
16. [Investigation of serum immunosuppresive acidic protein levels in gynecological tumor].
Zhang W; Wang P; Zhao Y
Zhonghua Yi Xue Za Zhi; 1999 Mar; 79(3):194-6. PubMed ID: 11601039
[TBL] [Abstract][Full Text] [Related]
17. [Clinical significance of vascular endothelial growth factor in sera of patients with gynaecological malignant tumors].
Peng XP; Li JD; Li MD; Ye XM; Yan WC
Ai Zheng; 2002 Feb; 21(2):181-5. PubMed ID: 12479072
[TBL] [Abstract][Full Text] [Related]
18. [Serum ferritin and trophoblastic globulin in genital tumors in women].
Griaznova IM; Borisenko SA; Markarov OV; Fomina MB; Prokopenko PG; Tatarinov IuS
Vopr Onkol; 1990; 36(2):181-7. PubMed ID: 2180208
[TBL] [Abstract][Full Text] [Related]
19. [The expressions and clinical significance of IGFBP-2, -3 in both serum and tumor tissues in patients with epithelial ovarian cancer].
Yan XJ; Tian Y; Wang C; Wang XL; Di JM; Cheng JX
Sichuan Da Xue Xue Bao Yi Xue Ban; 2009 Jul; 40(4):639-43. PubMed ID: 19764562
[TBL] [Abstract][Full Text] [Related]
20. [Pregnancy-associated alpha 2-glycoprotein in patients with gynecologic cancer].
Sawada M; Matsui Y; Okudaira Y; Shimizu Y; Takayama K
Nihon Sanka Fujinka Gakkai Zasshi; 1983 Apr; 35(4):451-8. PubMed ID: 6854093
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
